跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abstral - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abstral
Approved
STANDARD
Abstral
Aesica Queenborough Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f9a7a6c7e9b4af96
Company
Aesica Queenborough Limited
Type
Standard
Approval Details
Approval Id
f9a7a6c7e9b4af96
Drug Approval Philippines Name
Abstral
Product Name
Abstral
Registration Number
DR-XY45371
Brand Name
Abstral
Generic Name
Fentanyl (as Citrate)
Dosage Form
Sublingual Tablet
Dosage Strength
100 mcg (equivalent to 157.1 mcg Fentanyl citrate)
Manufacturer
Aesica Queenborough Limited
Importer
A. Menarini Philippines, Inc.
Company Detail Path
/organization/aesica-queenborough-limited
Issuance Date
09 March 2022
Expiry Date
11 May 2026
Pharmacologic Category
Opioid Analgesic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f9a7a6c7e9b4af96
Type
Standard
Back to Philippines FDA Approvals